Matricelf Ltd (MTLF.TA)
Tel Aviv · ILA · Healthcare · Biotechnology
ILA 242.00 (+0.79%) as of
Key statistics
- Market cap
- 83.46M
- Dividend yield
- 0.00%
- 52-week range
- 212.00 – 853.00
- Beta
- 0.37
- Profit margin
- 0.00%
- Volume
- 66.89k
About Matricelf Ltd
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. The company has a strategic collaboration with Sheba Medical Center for the development and clinical advancement of its neural tissue implant product for the treatment of spinal cord injury; and CiRA Foundation for the development of regenerative manufacturing technologies and the evaluation of iPSC-based neural tissue engineering for therapeutic applications. The company was incorporated in 2019 and is based in Ness Ziona, Israel.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Ness Ziona, Israel
- Employees
- 15
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.